Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00021217
DRKS00021217
Suspended
未知

Dynamic whole body data acquisition in PET/CT diagnostics: a prospective data collection in clinically indicated examinations - dyn. PET

niversitätsklinikum Tübingen, Radiologische Klinik, Nuklearmedizin & Klinische Molekulare Bildgebung0 sites300 target enrollmentMarch 31, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOncological diseases.Inflammatory forms of disease (e.g. fever of unclear origin, vasculitis, spondylodiscitis or unclear inflammation in the chest / pulmonary etc.)C15.9C43C83C14C32C80C19C53C54C85I77Oesophagus, unspecifiedMalignant melanoma of skinNon-follicular lymphomaMalignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynxMalignant neoplasm of larynxMalignant neoplasm, without specification of siteMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of cervix uteriMalignant neoplasm of corpus uteriOther and unspecified types of non-Hodgkin lymphomaOther disorders of arteries and arterioles

Overview

Phase
未知
Intervention
Not specified
Conditions
Oncological diseases.Inflammatory forms of disease (e.g. fever of unclear origin, vasculitis, spondylodiscitis or unclear inflammation in the chest / pulmonary etc.)
Sponsor
niversitätsklinikum Tübingen, Radiologische Klinik, Nuklearmedizin & Klinische Molekulare Bildgebung
Enrollment
300
Status
Suspended
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Tübingen, Radiologische Klinik, Nuklearmedizin & Klinische Molekulare Bildgebung

Eligibility Criteria

Inclusion Criteria

  • •Clinical indication for a PET/CT examination
  • •Patients with a malignant or inflammatory disease
  • •Patients who are able to understand the nature and scope of the pseudonymized, prospective data collection
  • •Patients who tolerate 80 min measuring time in the PET/CT scanner
  • •Age \=18 years
  • •Written consent of the patient

Exclusion Criteria

  • •Pregnant and lactating women,
  • •Patients with claustrophobia,
  • •Patients with problems/pain when lying on their back, who may not tolerate a measurement time of more than one hour,
  • •Exclusion criteria according to the Radiation Protection Ordinance (StrlSchV),
  • •The patient's limited ability to consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Dynamic whole-body [18F]FDG-PET/CT for patients with lung cancerC34Malignant neoplasm of bronchus and lung
DRKS00017717niversitätsklinikum Tübingen, Nuklearmedizin38
Recruiting
Not Applicable
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under ImmunotherapyMetastatic Melanoma
NCT04272658University Hospital, Brest56
Recruiting
Not Applicable
Automated analysis of whole body FDG PET/CT Data using Machine Learning methodsC34C81C83C43Malignant neoplasm of bronchus and lungHodgkin lymphomaNon-follicular lymphomaMalignant melanoma of skin
DRKS00026991Klinikum der Universität München, Campus Großhadern2,000
Recruiting
Not Applicable
C11-PBR28 Whole-body imaging by PET/CT in normal volunteerormal volunteer
JPRN-UMIN000005069Department of Nuclear Medicine, Osaka University Hospital30
Recruiting
Not Applicable
Dynamic Whole-body PET/CT Imaging in Clinical OncologyCancer
NCT06424873Valentina Garibotto60